PROJECT MANAGEMENT IN PHARMACEUTICAL INDUSTRY
Keywords:
pharmaceutical industry, pharmaceutical companies, project management, drug developmentAbstract
Driving a product to the market safely, quickly, and cheaply is the best way for a pharmaceutical company to be successful. In the era of an increased consumer demand for pharmaceutical products, the complex process of new product development has to be shortened as much as possible without damaging the overall quality and efficacy of the new product. The pharmaceutical industry is booming, and the race in delivering new products to the market is speeding up. Pharmaceutical companies encounter enormous challenges during the long and extremely complex product-development process. From the initial research in the early laboratory stages until the ultimate product market launch, this long process includes management in a number of different business processes, such as technical development using quality by design, regulatory strategy, clinical studies, and supply chain. To be able to find the most cost-effective ways of speeding up the process of development of new products, and particularly of the clinical trial phase, pharmaceutical companies faced up the need of introducing and implementing project management, which in other manufacturing industries was done a long time ago. Identification of risks of each of the phases in the process and an effective risk mitigation plan became key factors for success for these companies, both from financial and technical perspective. However, implementation of effective project management in launching new products does not only support the success and profitability of pharmaceutical companies. Effective project management in the pharmaceutical industry also makes available new medical discoveries for patients in need sooner and at lower costs, and by enabling a treatment for a certain disease supports maintenance of human health and improves the quality of life worldwide. The article begins with introduction, continues with the interconnection between the new product development and the need of implementing project management in the pharmaceutical industry, refers to the planning of clinical trials of new products as a very important phase of the business life cycle in this industry, explains the basic definition of project management in the pharmaceutical industry and its specifics, and ends with a conclusion.
References
A CBO Study (2006). Research and Development in the Pharmaceutical Industry, The Congress of the United States & Congressional Budget Office, Washington D.C., p. 19
Blomquist, T., & Muller, R. (2006). “Practices, roles, and responsibilities of middle managers in program and portfolio management”, Project Management Journal, Vol. 37, John Wiley & Sons Ltd, Hoboken, New Jersey, pp. 52-66.
Brown, L., & Grundy, T. (2004).Project management for the pharmaceutical industry, Gower Publishing Ltd., Burlington, p. 118
Drug Discovery and Development (2007). "Understanding the R&D Process", Phrma, Washington DC, p.5
D. L. Raemdonck & B. A. Burns (2018), Drug Development project management. Chapter 4. Available at: https://onlinelibrary-wileycom.proxy.findit.dtu.dk/doi/pdf/10.1002/9780470636930.ch4""
Engwall, M., & Jerbrant, A. (2003). “The resource allocation syndrome: the prime challenge of multi-project management?”, International Journal of Project Management, ELSEVIER Vol. 21, Amsterdam, pp. 403-409
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). (2012). “The Pharmaceutical Industry and Global Health”: Facts and Figures 2012 Retrieved on 01 March 2014 fromhttp://ifpma.org
IQVIA Institute for Human Data Science (April, 2019). The Changing Landscape of Research and Development. https://tinyril.com/y2kpxve8. p.7.
New Drug Product Exclusivity, 21 C.F.R. § 314.108 (2020)
Pattanaik, A. (2014). “Complexity of project management in the pharmaceutical industry”. Paper present at PMI Global Congress 2014 – EMEA, Dubai, United Emirates. PMI.https://www.pmi.org/learning/library/project-management-complexity- pharmaceutical-industry-1487
Parikh, D. (2001). “Formulation development”, Contract Pharma, London, pp.60-64 http://ContractPharma.com
Pharma Figures Report (2018). Available at: https://www.efpia.eu/media/361960/efpia-pharmafigures2018_v07-hq.pdf/EFPIA"
Pharmaceutical Research and Manufacturers of America 2020, PhRMA Annual Membership Survey (PhRMA, 2020), https://tinyurl.com/ydh6p64t, and 2019 PhRMA Annual Membership Survey (PhRMA,2019), https://tinyurl.com/ycvneve7 (PDF, 2.15 MB) "Pattanaik, A.Complexity of project management in the pharmaceutical industry. Paper presented at PMI® Global Congress 2014—EMEA, Dubai, United Arab Emirates. Newtown Square, PA: Project Management Institute. - Available at: https://www.pmi.org/learning/library/project-management-complexity-pharmaceutical-industry-1487 "
Pharmaceutical Research and Manufacturers of America. (June, 2005) Washington, DC . What goes into the cost of prescription drugs?
Rang, H. P., Dale, M. M., Ritter, J. M., & Moore, P. K. (2003). Pharmacology, Fifth edition, Churchill Livingstone, London, pp.747-751
Roberts, P. (1999).“Product innovation, product market competition and persistent profitability in the U.S. pharmaceutical industry”, Strategic Management Journal, John Wiley & Sons Ltd, Hoboken, New Jersey, pp. 655-670
Shah, V. (2017). “The Implication of Agile&traditional Method as a Practice in Pharmaceutical Industry”.Retrieved from http://digitalcommons.harisburgu.edu/pmgt_dandt/15; p.6
Thomsett, R. (2002). Radical Project Management, Prentice Hall, Upper Saddle River, New Jersey, pp. 56-64
